Press Release
Aug 16, 2019
DENVER – Weini Qiu, a lung cancer advocate from Shanghai, China, will be recognized by the International Association for the Study of Lung Cancer (IASLC) at the IASLC 2019 World Conference on Lung Cancer (WCLC) in Barcelona, Spain. Qiu will accept the Advocate Travel Award, which is given to five individuals to help them attend and participate in the IASLC WCLC.
After Qiu’s father passed away in 2015 from lung cancer, he launched a start-up called Haalthy to accelerate drug approval in China by using data. He decided to quit his engineering job and focus on helping cancer patients and gaining more insight into lung cancer research.
Qiu organized a patient/advocate meeting during the IASLC Asia Conference on Lung Cancer 2018. The meeting encouraged participants to become more active within their own provinces and take on roles to promote lung cancer awareness.
“By attending the WCLC, I hope to learn the most updated treatment strategies and frontier research that are initiated by or partnered with advocacy groups so that I can bring the knowledge back to China in order to build a better foundation and community that will benefit patients and family members,” said Qiu.
As an Advocate Travel Award recipient, Qiu will receive complimentary conference registration, a fixed monetary amount to help offset travel costs, four nights’ accommodation at one of the conference contracted hotels and free IASLC membership for 2020, allowing Qiu to continue his education and lung cancer advocacy work.
About the WCLC:
The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 countries. The goal is to increase awareness, collaboration and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit wclc2019.iaslc.org.
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.